• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2203-30C
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Emotional Changes (1831); Cramp(s) /Muscle Spasm(s) (4521)
Event Date 08/05/2022
Event Type  Injury  
Event Description
It was reported that the clinical study patient (a4092 cartesia extend 3d study) experienced a serious adverse event of acute change of nature, psychomotor agitation, and hyperkinesia which was due to accidental change in dbs program, with moderate severity.The patient was admitted to the hospital, medication was given and the device was reprogrammed.Stimulation was returned to the original program which showed significant improvement of psychomotor agitation, the stimulaiton was reduced to address the hyperkinesia.The patient showed clinical improvement and was discharged three days later.The event relationship to procedure and stimulation were reported as possible.The event resolved.
 
Manufacturer Narrative
Additional suspect medical device component involved in the event: product family: dbs-linear leads.Upn: m365db220330c0.Model: db-2203-30c.Serial: (b)(6).Batch: 5000410.
 
Manufacturer Narrative
E1: initial reporter phone: (b)(6).Additional suspect medical device component involved in the event: product family: dbs-linear leads, upn: m365db220330c0, model: db-2203-30c, serial: (b)(6), batch: (b)(6).
 
Event Description
It was reported that the clinical study patient (a4092 cartesia extend 3d study) experienced a serious adverse event of acute change of nature, psychomotor agitation, and hyperkinesia which was due to accidental change in dbs program, with moderate severity.The patient was admitted to the hospital, medication was given and the device was reprogrammed.Stimulation was returned to the original program which showed significant improvement of psychomotor agitation, the stimulation was reduced to address the hyperkinesia.The patient showed clinical improvement and was discharged three days later.The event relationship to procedure and stimulation were reported as possible.The event resolved.Additional information was provided that the event was not related to the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key15353495
MDR Text Key331973293
Report Number3006630150-2022-04512
Device Sequence Number1
Product Code NHL
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/15/2022
Device Model NumberDB-2203-30C
Device Catalogue NumberDB-2203-30C
Device Lot Number5000410
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/09/2022
Initial Date FDA Received09/03/2022
Supplement Dates Manufacturer Received09/13/2022
02/14/2023
Supplement Dates FDA Received10/07/2022
03/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/15/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age53 YR
Patient SexFemale
-
-